Clarity Pharmaceuticals Ltd (ASX:CU6) Directors Insider Transactions
The Directors and Chief Executives of Clarity Pharmaceuticals Ltd (ASX:CU6) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Clarity Pharmaceuticals Ltd's shares in the stock market. Below table shows the list of insider transactions as reported by Clarity Pharmaceuticals Ltd to the ASX stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Clarity Pharmaceuticals Ltd Directors/Insider Transactions Activity
List of Insider trades activity from Clarity Pharmaceuticals Ltd (CU6).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 01 Aug 2025 | Roberts (Christopher Graham) | Director (Non-Executive) | 200,000 | - | - |
| 01 Jul 2025 | Biggin (Colin David) | Chief Executive Officer | 592,373 | 616,838 | Exercise at price 1.04 per share. |
| 01 Jul 2025 | Parker (Michelle) | Director (Executive) | 296,186 | 308,418 | Exercise at price 1.04 per share. |
| 01 Jul 2025 | Taylor (Alan) | Executive Chairman | 592,373 | 616,838 | Exercise at price 1.04 per share. |
| 01 Oct 2024 | Biggin (Colin David) | Chief Executive Officer | 1,084,321 | 6,386,325 | Exercise at price 5.89 per share. |
| 01 Oct 2024 | Parker (Michelle) | Director (Executive) | 542,710 | - | - |
| 01 Oct 2024 | Ramdahl (Thomas) | Director (Non-Executive) | 200,000 | 113,540 | Exercise at price 0.57 per share. |
| 01 Oct 2024 | Roberts (Christopher Graham) | Director (Non-Executive) | 200,000 | - | - |
| 01 Oct 2024 | Taylor (Alan) | Executive Chairman | 1,083,776 | - | - |
| 20 Sep 2024 | Parker (Michelle) | Director (Executive) | 535,000 | - | - |
| 17 Sep 2024 | Robinson (Rosanne) | Director (Non-Executive) | 178,079 | - | - |
| 23 Aug 2024 | Thomas (Robert Bain) | Former | 290,000 | - | - |
| 07 Aug 2024 | Biggin (Colin David) | Chief Executive Officer | 905,625 | - | - |
| 01 Aug 2024 | Biggin (Colin David) | Chief Executive Officer | 542,835 | - | - |
| 01 Aug 2024 | Taylor (Alan) | Executive Chairman | 543,002 | - | - |
| 20 May 2024 | Thomas (Robert Bain) | Independent Non-Executive Director | 8,333 | 23,804 | Purchase at price 2.86 per share. |
| 20 May 2024 | Thomas (Robert Bain) | Independent Non-Executive Director | 909 | 2,668 | Purchase at price 2.94 per share. |
| 20 May 2024 | Thomas (Robert Bain) | Independent Non-Executive Director | 2,424 | 6,965 | Purchase at price 2.87 per share. |
| 20 May 2024 | Thomas (Robert Bain) | Independent Non-Executive Director | 4,242 | 11,894 | Purchase at price 2.80 per share. |
| 20 Apr 2024 | Thomas (Robert Bain) | Independent Non-Executive Director | 16,667 | 27,272 | Purchase at price 1.64 per share. |
| 20 Apr 2024 | Thomas (Robert Bain) | Independent Non-Executive Director | 9,091 | 14,875 | Purchase at price 1.64 per share. |
| 20 Apr 2024 | Thomas (Robert Bain) | Independent Non-Executive Director | 7,576 | 12,396 | Purchase at price 1.64 per share. |
| 20 Apr 2024 | Thomas (Robert Bain) | Independent Non-Executive Director | 758 | 1,240 | Purchase at price 1.64 per share. |
| 21 Mar 2024 | Ramdahl (Thomas) | Director (Non-Executive) | 400,000 | 158,960 | Exercise at price 0.40 per share. |